In 2017, Carla was recognized for excellence with a tier one patent prosecution ranking by "Leaders League" in their annual Innovation Technology & IP rankings.

Carla Ji-Eun Kim

Director

ckim@sternekessler.com
+1 202.772.8619
LinkedIn

Overview

Carla Ji-Eun Kim is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. She also serves as the chair of the firm’s Patent Prosecution Practice. Carla advises a diverse group of biotechnology companies on building worldwide exclusivities around their products. In her practice, Carla focuses on finding and creating innovative ways to extend exclusivities that are well integrated with her clients’ technological and business objectives. For example, Carla counsels her clients on the preparation, prosecution, and management of complex worldwide patent portfolios in areas of biotechnology such as therapeutic antibody, therapeutic fusion protein, antisense technology, personalized medicine, vaccine, gene therapy, cell therapy, formulation, bioinformatics, and upstream and/or downstream protein manufacturing process.

Carla also has extensive experience in IP due diligence investigations and freedom to operate studies, and she prepares patentability, validity, and noninfringement opinions in connection with licensing, acquisition, and investment.

Carla received her J.D. from the University of Minnesota Law School, cum laude, her M.S. in pharmacology from the University of Minnesota and her M.S. in cell and molecular biology from the University of Pennsylvania. Carla’s graduate research focused on molecular genetic mechanisms of DNA repair in mammalian cancer cells and developing an anti-angiogenic approach to cancer therapy and treatment. She earned her B.A. in biology, magna cum laude, from the University of Wisconsin, Stevens Point.

Carla is an Adjunct Professor at George Mason University Antonin Scalia Law School, teaching patent prosecution. When not at work, Carla loves yoga and hiking on the weekends.

Accolades

  • IAM Patent 1000, “Washington, DC: Recommended – Patent Prosecution” (2023 – 2022)
  • LMG Life Sciences, “Finalist – Patent Strategy Attorney of the Year – DC Metro” (2022)
  • Managing IP, “IP Star” (2023 – 2022)
  • LMG Life Sciences, “Life Sciences Star” (2023 – 2020)
  • Profiles in Diversity Journal, “Women Worth Watching® in STEM” (2020)
  • Leaders League, “Innovation Technology & IP Rankings – Tier One, Patent Prosecution” (2017)

Education

  • J.D., University of Minnesota Law School, cum laude
  • M.S., Pharmacology, University of Minnesota
  • M.S., Cell & Molecular Biology, University of Pennsylvania
  • B.A., Biology, University of Wisconsin - Stevens Point, magna cum laude

Admissions

  • District of Columbia

Languages Spoken

  • Korean

Events

Speaking Engagement 2023 Focus on Pharma Washington, DC, April 14, 2023
Speaking Engagement Written Description and Enablement: Current Cases and Pending Decisions Alexandria, VA & Virtual, March 23, 2023
Speaking Engagement Managing International IP Strategy Amidst A Shifting Global IP Landscape Virtual, December 7, 2020
Speaking Engagement Industry Review 2020: Life Sciences Virtual, November 30, 2020
Speaking Engagement MIP Life Sciences Forum 2019 New York, NY, September 18, 2019
Speaking Engagement MIP Life Sciences Forum 2018 New York, NY, September 12, 2018

Related Resources From Carla Ji-Eun Kim

In the News Raise Your Wands: Counsel Welcome USPTO's Enablement Guidance Managing IP January 11, 2024
In the News Four US patent trends to watch in 2024 Managing IP January 4, 2024
In the News Patent Policy To Watch In 2024 Law360 January 1, 2024
In the News Not So Secret Agents: Firms Eye Patent Drafting Efficiencies Managing IP November 3, 2023
Press Release LMG Life Sciences Ranks Sterne Kessler and Seven Directors for Patent Litigation and Prosecution Sterne, Kessler, Goldstein & Fox September 21, 2023
In the News Biotech 'New Era' in Store if Patent Revamp Overcomes Opposition Bloomberg Law October 17, 2022
In the News New Patent Bill Could Boost Diagnostics, but Needs Work Law360 August 12, 2022
In the News Inside the Life of a Patent Prosecution Boss Managing IP October 22, 2021
Press Release Sterne Kessler and Seven Directors Earn Top-Tier Designations in 2021 LMG Life Sciences Rankings Sterne, Kessler, Goldstein & Fox September 29, 2021
In the News Managing Rejection: How In-House Revive Failed USPTO Patents Managing IP July 14, 2021
Press Release Firm and Seven Directors Recognized in 2020 LMG Life Sciences Rankings Sterne, Kessler, Goldstein & Fox P.L.L.C. October 6, 2020
In the News Managing IP America Awards 2019 Winners Revealed Managing Intellectual Property April 8, 2019